Consequently, in advanced-stage tumors, TGFβ plays a key role in shaping the tumor-promoting TME and driving immune evasion, where CAFs are activated and TAMs are polarized toward the M2 phenotype with both cell types being the major sources of TGFβ [8,10,40,41]. The gene discussed is TGFB1; the disease is neoplasm.